Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07892885) titled 'A Clinical Trial to Evaluate the Efficacy and Safety of Meltz, a Digital Therapeutic Device, for Improving Panic Symptoms in Patients With Panic Disorder' on Oct. 19.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
Primary Sponsor: AIMNEXT
Condition:
Panic Disorder
Agoraphobia
Intervention:
Device: Meltz
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 2026
Target Sample Size: 120
To know more, visit https://clinicaltrials.gov/study/NCT07892885
Disclaimer: ...